Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases. The management […]

The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy […]

Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals […]

Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to […]